pharmanews1 님의 블로그

The global Continuous Glucose Monitoring (CGM) Market is witnessing robust growth, driven by a convergence of technological innovations, rising diabetes incidence, and the growing emphasis on remote healthcare. Valued at US$ 5.8 Bn in 2024, the market is projected to more than double, reaching US$ 12.6 Bn by 2035, expanding at a CAGR of 7.4% during the forecast period.Revolutionizing Diabetes Ma..

The U.S. ambulatory infusion centers market is undergoing a robust transformation, becoming a cornerstone of modern chronic disease management. Valued at US$ 8.9 Bn in 2024, the market is projected to surge to US$ 22.5 Bn by 2035, growing at a strong CAGR of 8.8% during the forecast period. This growth reflects an increasing shift towards cost-effective, patient-centric, and technology-driven ou..

The global Brain-Computer Interface (BCI) market is poised for significant transformation, driven by rapid technological advancements, increasing neurological disorders, and rising adoption across both healthcare and non-medical sectors. With growing interest in human-machine integration, BCI technology is no longer confined to science fiction — it is emerging as a practical solution in real-wor..

The global regulatory affairs outsourcing market is entering a period of robust expansion, fueled by the growing intricacy of international compliance requirements, cost pressures on pharmaceutical and biotech companies, and the rising number of clinical trials across diverse therapeutic areas. According to a recent report by Transparency Market Research, the market was valued at US$ 7.4 Bn in 2..